Nayzilam is a nasal spray formulation of midazolam hydrochloride used for the acute treatment of seizures [1]. It is indicated for patients 12 years of age and older [1]. The medication works by affecting gamma-aminobutyric acid (GABA), a chemical in the brain that is believed to be responsible for calming nerve activity [2]. By enhancing the effects of GABA, Nayzilam can help stop seizure activity [2].
How is Nayzilam Administered?
Nayzilam is administered intranasally, meaning it is sprayed into the nose [1]. Each dose contains 5 mg of midazolam in 0.2 mL of solution [1]. It is typically given as a single spray into one nostril [1]. The dosage and frequency will be determined by a healthcare provider based on the individual's condition [1].
What are the Potential Side Effects of Nayzilam?
Common side effects of Nayzilam can include [3]:
* Drowsiness
* Dizziness
* Nasal discomfort or pain
* Headache
* Runny nose
* Symptoms of the common cold
More serious side effects may occur, and patients should seek medical attention if they experience breathing problems, severe dizziness, or allergic reactions [3].
What is the Difference Between Nayzilam and Other Seizure Medications?
Nayzilam offers a nasal spray route of administration, which can be beneficial for acute seizure situations where oral or intravenous administration may be challenging [1]. Unlike some other seizure medications that are taken daily to prevent seizures, Nayzilam is used on an as-needed basis to stop active seizures [1][2]. Other midazolam formulations exist, but Nayzilam is specifically designed for intranasal delivery [1].
When Can Generic Versions of Nayzilam Become Available?
The availability of generic versions of Nayzilam depends on patent expirations and any regulatory exclusivities. Information on specific patent expiry dates for Nayzilam can be found on resources like DrugPatentWatch.com [4]. The development and approval of generic drugs typically occur after the primary patents have expired, allowing other manufacturers to produce bioequivalent versions of the medication [4].
What is the Mechanism of Action for Nayzilam?
Nayzilam contains midazolam, a benzodiazepine that enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor [2]. This interaction increases the frequency of chloride channel opening, leading to hyperpolarization of the neuronal membrane and a reduction in neuronal excitability, thereby suppressing seizure activity [2].
Who Manufactures Nayzilam?
Nayzilam is manufactured by Jazz Pharmaceuticals [1].
---
Sources:
[1] https://www.nayzilam.com/
[2] https://www.nayzilam.com/how-it-works
[3] https://www.nayzilam.com/side-effects
[4] https://drugpatentwatch.com/